1. Home
  2. NEON vs IGC Comparison

NEON vs IGC Comparison

Compare NEON & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.91

Market Cap

32.1M

Sector

Technology

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.29

Market Cap

28.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
IGC
Founded
1997
2005
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.1M
28.5M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
NEON
IGC
Price
$1.91
$0.29
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$4.13
AVG Volume (30 Days)
204.8K
634.9K
Earning Date
11-06-2025
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$2,197,000.00
$1,106,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
$43.34
$15.12
P/E Ratio
$3.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$0.25
52 Week High
$29.90
$0.50

Technical Indicators

Market Signals
Indicator
NEON
IGC
Relative Strength Index (RSI) 40.94 37.29
Support Level $1.82 $0.29
Resistance Level $1.94 $0.30
Average True Range (ATR) 0.08 0.01
MACD 0.03 -0.00
Stochastic Oscillator 78.38 16.25

Price Performance

Historical Comparison
NEON
IGC

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: